Form CORRESP - Correspondence:
SEC Accession No. 0001628280-21-000216
Filing Date
2021-01-06
Accepted
2021-01-06 17:15:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10089
2 CORRESP cumberlandlogo1a.jpg GRAPHIC 12332
  Complete submission text file 0001628280-21-000216.txt   22708
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations